Latest news
FDA grants Lilly’s Olomorasib breakthrough therapy status in rare pancreatic cancer fight - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 14:18:22 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMTEli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer - webull.comwebull.com · Wed, 05 Aug 2026 03:05:59 GMTOlomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMTLilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVEPMLiVE · Tue, 04 Aug 2026 10:55:00 GMTFDA Grants Breakthrough Status to Olomorasib in Pancreatic Cancer - Targeted OncologyTargeted Oncology · Mon, 03 Aug 2026 20:07:34 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR NewswirePR Newswire · Mon, 03 Aug 2026 11:45:00 GMT